Anzeige
Mehr »
Login
Montag, 20.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Aktienchance des Jahres! Ihre Chance auf explosive Gewinne!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0JDT8 | ISIN: DK0060030286 | Ticker-Symbol: C6F
Tradegate
20.01.25
16:41 Uhr
27,150 Euro
+2,250
+9,04 %
Branche
IT-Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
CBRAIN A/S Chart 1 Jahr
5-Tage-Chart
CBRAIN A/S 5-Tage-Chart
RealtimeGeldBriefZeit
26,60026,75019:56
26,60026,75019:41
GlobeNewswire (Europe)
74 Leser
Artikel bewerten:
(0)

cBrain A/S: cBrain raises expected 2024 EBT margin to 30-32%

Finanznachrichten News

Company Announcement no. 01/2025

cBrain raises expected 2024 EBT margin to 30-32%

Copenhagen, January 20, 2025

For the year 2024, cBrain (NASDAQ: CBRAIN) has forecasted revenue growth of 10-15% and earnings before tax (EBT) of 24-30%.

Revenue growth is now narrowed from 10-15% to 12-13%, aligning with the middle of the previous range. In parallel cBrain raises expected EBT from 24-30% to 30-32%. The expected revenue growth is in line with the three-year growth plan, while earnings exceed expectations.

Due to faster-than-expected global industry changes as well as market uncertainties in the US and Germany, cBrain has held back some of the market investments, which were planned for in 2024. Instead cBrain has taken a number of initiatives to adapt its go-to-market strategy and organization to take advantage of the changing market situation. This has resulted in costs being lower than expected.

--

In 2022, cBrain announced its 2023-2025 growth plan with the goal of consolidating the business model and preparing for long-term growth by positioning itself as a supplier of climate software and developing a partner model. Over the past two years, cBrain has successfully executed this plan. This includes gaining market share, initiating partnerships, and delivering solid results and cash flow.

The growth plan is based on the assumption that government organizations over time will switch from relying on custom-built solutions and best-of-breed architectures to using standard software. The government IT industry is massive and dominated by large suppliers who benefit from consultancy fees and billable hours. This creates significant entry barriers as the classic vendors defend their business, and the growth plan therefore anticipates a slow transition to standard software.

Contrary to these assumptions, cBrain now sees indications that industry shifts toward standard software and platforms are occurring faster than anticipated. Fueled by a lack of skilled IT resources and a growing demand for fast delivery, cBrain sees a rapidly emerging IT industry, referred to as Commercial Off-The-Shelf (COTS) for government. For cBrain, this presents new strategic opportunities.

COTS for government, leveraging new technologies and platforms such as the F2 Digital Platform, enables digital transformation at higher speed and lower costs that outperform traditional IT modernization. For example, cBrain delivered a complete end-to-end digital platform for two new Danish ministries within just three weeks during the autumn of 2024. Traditionally, projects of this nature take years and often fail, and the Danish ministerial cases thereby exemplify the power of the COTS for government approach.

The long-term cBrain growth strategy is founded on a vision and a business case to provide standard software for government. Over the past 15 years, cBrain has invested more than 450,000 hours in developing the F2 platform. With a solid first-mover advantage and a strong customer base, cBrain is well-positioned to become a leading international software provider of COTS for government solutions.

During the year 2024, the accelerated market shift and the power of the COTS for government approach have opened new opportunities for cBrain. This is exemplified by the recent collaboration between cBrain and UNDP in Africa to support the UNDP Digital Offer for Africa strategy, and larger orders in Romania helping to modernize traditional mainframe type solutions.

The faster-than-expected market shift, with government looking toward IT modernization and digitization based on the alternative COTS for government approach, clearly represents a very positive development for cBrain.

cBrain wants to fully take advantage of this, and the solid business with strong cash flow and earnings offers strategic flexibility. Consequently, cBrain has decided to revisit and potentially adjust its international growth strategy. This includes evaluating organizational readiness, as well as market and product development strategies, to leverage and make the most of the accelerated industry changes.

cBrain publishes its annual report 2024 on 20. February 2025.

Best regards

Per Tejs Knudsen, CEO

Inquiries regarding this Company Announcement may be directed to

Ejvind Jørgensen, CFO & Head of Investor Relations, cBrain A/S, ir@cbrain.com, +45 2594 4973


© 2025 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.